AU2596901A - Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer - Google Patents
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerInfo
- Publication number
- AU2596901A AU2596901A AU25969/01A AU2596901A AU2596901A AU 2596901 A AU2596901 A AU 2596901A AU 25969/01 A AU25969/01 A AU 25969/01A AU 2596901 A AU2596901 A AU 2596901A AU 2596901 A AU2596901 A AU 2596901A
- Authority
- AU
- Australia
- Prior art keywords
- kits
- assessment
- therapy
- prevention
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G01N33/57515—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17140699P | 1999-12-21 | 1999-12-21 | |
| US60171406 | 1999-12-21 | ||
| US17642300P | 2000-01-14 | 2000-01-14 | |
| US60176423 | 2000-01-14 | ||
| US19047100P | 2000-03-17 | 2000-03-17 | |
| US60190471 | 2000-03-17 | ||
| US19348200P | 2000-03-29 | 2000-03-29 | |
| US60193482 | 2000-03-29 | ||
| US20523100P | 2000-05-15 | 2000-05-15 | |
| US60205231 | 2000-05-15 | ||
| US21323600P | 2000-06-20 | 2000-06-20 | |
| US60213236 | 2000-06-20 | ||
| US21986500P | 2000-07-20 | 2000-07-20 | |
| US60219865 | 2000-07-20 | ||
| PCT/US2000/035214 WO2001046697A2 (en) | 1999-12-21 | 2000-12-21 | Identification, assessment, prevention, and therapy of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2596901A true AU2596901A (en) | 2001-07-03 |
Family
ID=27569123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU25969/01A Abandoned AU2596901A (en) | 1999-12-21 | 2000-12-21 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2596901A (en) |
| WO (1) | WO2001046697A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7402660B2 (en) | 2000-08-02 | 2008-07-22 | The Johns Hopkins University | Endothelial cell expression patterns |
| US7171311B2 (en) | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
| JP2005500832A (en) | 2001-06-18 | 2005-01-13 | ロゼッタ・インファーマティクス・インコーポレーテッド | Diagnosis and prognosis of breast cancer patients |
| AT410945B (en) * | 2001-06-27 | 2003-08-25 | Burkhard Dr Jansen | Diagnosis of multiple sclerosis or tumors, by detecting absence of wild-type stem cell factor-apoptosis response gene, or the derived protein, also new nucleic acids |
| WO2003087122A2 (en) * | 2002-04-12 | 2003-10-23 | Molecular Engines Laboratories | Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| WO2003087154A2 (en) * | 2002-04-12 | 2003-10-23 | Molecular Engines Laboratories | Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| WO2005095981A1 (en) | 2004-03-31 | 2005-10-13 | Perseus Proteomics Inc. | Cancer diagnosis and treatment using anti-robo1 antibody |
| US8940488B2 (en) | 2004-03-31 | 2015-01-27 | Hiroyuki Aburatani | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody |
| EP1926747A1 (en) | 2005-08-12 | 2008-06-04 | Schering Corporation | Mcp1 fusions |
| JP5117765B2 (en) | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | Tumor diagnostic agent for PET containing anti-ROBO1 antibody |
| US8524217B2 (en) | 2010-05-11 | 2013-09-03 | Merck Sharp & Dohme Corp. | MCP1-Ig fusion variants |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE125626T1 (en) * | 1984-01-06 | 1995-08-15 | Univ California | CYTOKERATIN TUMOR MARKER AND TEST FOR THE DETECTION THEREOF. |
| US5188964A (en) * | 1990-04-12 | 1993-02-23 | Board Of Regents, The University Of Texas System | Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination |
| WO1998008947A1 (en) * | 1995-12-19 | 1998-03-05 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Enhancement of dna immunization through the use of cytokines |
| US5914238A (en) * | 1996-06-05 | 1999-06-22 | Matritech, Inc. | Materials and methods for detection of breast cancer |
| US6500937B1 (en) * | 1996-10-03 | 2002-12-31 | University Of Michigan | Nucleotide sequence encoding a mammary cell growth inhibitor |
| AUPO500997A0 (en) * | 1997-02-07 | 1997-03-06 | Macquarie Research Limited | Diagnosis of disease using tears |
-
2000
- 2000-12-21 WO PCT/US2000/035214 patent/WO2001046697A2/en not_active Ceased
- 2000-12-21 AU AU25969/01A patent/AU2596901A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001046697A2 (en) | 2001-06-28 |
| WO2001046697A3 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001241541A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer | |
| AU2074201A (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2002337657A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| AU2002324451A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
| AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU4592601A (en) | Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU7701100A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| AU2001245295A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2002241720A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2001238493A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |